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The monomeric IgM and IgD molecules on the cell surface of B lymphocytes are 
generally thought to be integral membrane antigen receptors (1-3). These molecules 
are believed to be involved in triggering B cell activation (4-6) and, as such, might be 
expected to be structurally different  from their secreted homologues (at  least  in  the 
case of IgM). Currently there are conflicting reports as to the chemical nature of the 
difference  between  membrane  and  secreted  IgM  (7-10),  but  there  appears  to  be 
general agreement that the two molecules are structurally different (11-13). 
Subpopulations of B cells  also have been shown to express surface IgG (1,  14-16). 
Because IgG may be the only antigen  receptor on the most mature memory B cell 
subpopulation (17), membrane IgG also might be expected to be structurally different 
from its secreted homologue. 
In  this  communication, we show that  there  are  distinct  membrane and  secreted 
IgG2, molecules, distinguished by biochemical and serological criteria. The membrane 
IgGza studied  here  is  derived  from  a  cloned B-lymphoma cell  line,  2PK3  (18,  19), 
which  produces  both  membrane  and  secreted  IgG2~ immunoglobulin.  The  heavy 
chain constant  region of the secreted  immunoglobulin is  the  gene product of the a 
allele of the Igh-1  locus (20).  We demonstrate two major differences between mem- 
brane and secreted molecules:  (a)  membrane and secreted  IgG2, heavy chains have 
different  apparent  molecular  weight  (Mr) 1 and  net  charge  as  shown  with  two- 
dimensional polyacrylamide gel  electrophoresis;  and  (b)  membrane IgG2a is missing 
an  allotypic determinant  present  on secreted  IgG~a as  detected  with  a  hybridoma- 
derived anti-Igh- la antibody. 
The significance of these observations for immunoglobulin gene organization and 
control of expression of membrane and secreted heavy chain homologues is discussed. 
We mention further the potential biological significance of the structural differences 
between membrane and secreted heavy chains for the regulation of immunoglobulin 
synthesis. 
Materials and Methods 
Tumor Cells.  The 2PK3 tumor cell line was obtained from Dr. Noel Warner,  University of 
New Mexico, Albuquerque,  N. M. Before any analyses of these tumor cells were undertaken, 
* Supported in part by grants GM-17367, AI-08917, and CA-04681 from the National Institutes of 
Health. 
' Abbreviations used in  this paper: BSA, bovine serum albumin; FCS, fetal calf serum; Mr,  apparent 
molecular weight(s); mRNA, messenger RNA(s); NP-40, Nonidet P-40; PBS, mouse-tonicity phosphate- 
buffered saline; SaC, Staphylococcus  aureus Cowan I strain; SDS, sodium dodecyl  sulfate; SV40, simian virus 
40; T, transformation; TSTA, tumor-specific transplantation antigen. 
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the cell line was cloned with the fluorescence-activated cell sorter (FACS, Becton, Dickinson 
FACS Systems, Mountain View, Calif.). Cells were routinely maintained in stationary flasks at 
37°C in RPMI-1640 medium (Irvine Scientific, Santa Ana, Calif.) that contained 15% fetal 
calf serum (FCS), 1 mM sodium pyruvate, 50 U/ml penicillin, and 50/~g/ml streptomycin in 
a humidified 7% CO2 in air atmosphere. 
Biosynthetic  Radiolabeling.  Immunoglobulin derived from 2PK3 cells was radiolabeled bio- 
synthetically by incubating the  cells  in lysine- and arginine-free RPMI-1640 medium that 
contained 10 #Ci/ml of both  [14C]lysine and [14C]arginine  (New  England Nuclear, Boston, 
Mass.) and 10% FCS. Cells also were labeled biosynthetically  with 20/~Ci/ml of [35S]methionine 
(Amersham Corp., Arlington Heights, Ill.) in methionine-free medium. Initial cell densities for 
isotope incorporation were  1-2 ×  106 cells/ml and incorporation times were  16-24 h at 37°C 
in a humidified 7% CO2 in air atmosphere. Supernates from biosynthetically labeled cultures 
were  used for  analysis of secreted  IgG. Cell extracts were used for  analysis of cellular IgG. 
Extracts were prepared by washing 2-4 ×  10  o radiolabeled cells twice  in serum-free medium 
and solubilizing the cell  pellet  in  1 ml of 0.5% Nonidet  P-40  (NP-40;  Particle Data,  Inc., 
Elmhurst, Ill.)  in 50 mM Tris-HC1, 0.15 M  NaCI, 5 mM EDTA, 0.02% sodium azide, and 50 
mM  phenylmethylsulphonylfluoride, pH  8.0.  Solubilizatiion was  for  20  min  on  ice  with 
occasional vortexing, followed  by centrifugation for  10  min at  12,000 g.  Cell extracts  and 
supernates were stored at -70°C. 
Cell Surface Radioiodination.  Ceil suspensions with viabilities >95% were surface-labeled by 
the lactoperoxidase method. 2 mCi of Na[125I] (Amersham Corp.) were used to label 5-10 x  107 
cells in 100-200/d of mouse-tonicity phosphate-buffered saline (PBS), pH 7.3 (7.7 g NaC1, 0.54 
g  KH2PO4,  and 2.27  g  Na2HPO4  per liter).  10 ~g of lactoperoxidase (Calbiochem-Behring 
Corp., American Hoechst  Corp., San Diego,  Calif.)  in 50/~1 of PBS were added to the cell 
suspension followed by four 10-/d pulses of H202 at increasing concentrations (0.001%, 0.003%, 
0.01%, and 0.03% in PBS) at 2-min intervals. 2 min after the last pulse, the cells were washed 
twice in 5 ml of PBS and solubilized as described. 
Immunoprecipitation.  Heat-killed and formalin-fixed  Staphylococcus aureus Cowan I strain (SAC) 
organisms (The Enzyme Center, Boston, Mass.)  were used for direct and indirect immunopre- 
cipitations (21) of cell extracts and culture supernates. Because the protein A coat protein of S. 
aureus binds mouse IgG2a (22), SaC was used to directly precipitate 2PK3 IgG2a immunoglobulin. 
For indirect immunoprecipitation with hybridoma antibodies (see below), it was necessary to 
precoat the SaC with these antibodies, saturating all protein-A-binding  sites. All the antibodies 
used were IgG2~ proteins. 1 mg of purified antibody incubated with 50/~1 of a  10% suspension 
of SaC for 20 min on ice was sufficient for saturation. Excess antibody was removed by washing 
the coated SaC three times in a high-sah-NP-40 wash buffer (0.5% NP-40, 50 mM Tris-HCl, 
0.45 M NaC1, and 0.02% NAN3, pH 8.3). To minimize nonspecific binding of labeled proteins 
to  SaC,  extracts  and  supernates  were  precleared  with  GPCo8  (Igh-la)  myeloma protein- 
saturated SaC.  1 ml of cell extract (representing 2 ×  106 cells) or 2 m[ of culture supernate was 
precleared with 20-50/LI of GPC-8-coated SaC, followed  by centrifugation for 10 min at  1,500 
g.  All immunoprecipitates were  washed  with  high-sah-NP-40 wash  buffer  (see above)  that 
contained 2 mM lysine, 2 mM arginine, 2 mM methionine, and 5 mM KI before gel analysis. 
Labeled proteins were eluted from the SaC with isoelectrofocusing sample buffer. (23). 
Polyacrylamide  Gel Electrophoresis.  The two-dimensional polyacrylamide gel system utilizing 
nonequilibrium pH-gradient electrophoresis for the first  dimension and  10% sodium dodecyl 
sulfate (SDS)-polyacrylamide gel eleetrophoresis for the second dimension has been described 
previously (24-26). One-dimensional SDS-polyacrylamide slab gels are identical to the second 
dimension of the two-dimensional system. Autoradiography of gels was from 1-3 d. Gels with 
14C- and 35S-labeled  proteins were exposed  to  Kodak No-screen film  (Eastman Kodak Co., 
Rochester,  N.  Y.)  at  room temperature; and gels with 125I-labeled proteins were  exposed to 
Kodak X-omat R  film at  -70°C with DuPoint Cronex Lighming-Plus intensifying screens 
(DuPont Instruments, Wilmington, Del.). 
Inhibition  of Glycosylation.  Tunicamycin blocks the formation of the dolichol pyrophosphate 
intermediate that  mediates core  oligosaccharide addition to  specific  asparagine residues of 
nascent polypeptide chains (27, 28). Because IgG heavy chains have a single N-acetylglucosa- 
minyl-asparagine-linked oligosaccharide  (29),  glycosylation of  IgG2a heavy  chains  can  be 
inhibited effectively  with tunicamycin (30). Inhibition of glycosylation was with 5/Lg/ml of 1262  LYMPHOCYTE  MEMBRANE  IgG 
TABLE  I 
Anti-Allotype Hybridoma Antibodies * 
Anti-Igh- la 
Name  Lab designa- 
tion 
Anti-Igh-4a 
Lab designa-  Name  tion 
Ig(la)8.3~:  20-8.3 
Ig(la)  9.8~  20-6.B8 
Ig(la) 14.4  21-74.4 
Ig(la) 15.3  21-66.3 
Ig(la/3a) 16.3  21-48.3 
Ig(la) 17.2  20-19.2 
Ig(4a) 10.91:  20-9.10 
* These  antibodies  were  produced  by  hybridoma cell  lines  generated  by 
somatic  cell hybridization of NS-1 myeloma  cells with  SJL  spleen  cells 
immunized with SJA/9 anti-pertussis antibodies  ([34]; V. T. Oi and L. A. 
Herzenberg. Manuscript  in preparation.).  All of these antibodies are IgG2a 
immunoglobulins and have HL chain composition (34, 35). 
These antibodies have been described previously (34). 
tunicamycin  (obtained  from  Dr.  Carol  Sibley,  University of Washington,  Seattle,  Wash.) 
present during biosynthetic labeling of 2PK3 cells with [aSS]methionine as described above. 
Removal of  N-Glycosidic-linked Oligosaccharide Chains.  Although the complex N-glycosidic-linked 
oligosaccharide found  on  already secreted IgG~  heavy chains  is resistant  to  hydrolysis by 
endoglycosidase H  (31,  32), the di-N-acetylchitobiose linkage of high mannose core oligosac- 
charides found on newly synthesized IgG heavy chains is susceptible to cleavage (33). Endogly- 
cosidase H hydrolysis was carried out by incubating 0.01 U of enzyme (Miles Laboratories Inc., 
Miles Research Products, Elkhart, Ind.) in 50 #1 of PBS with the SaC precipitate of biosyn- 
thetically labeled 2PK3  cells for  1 h  at  room  temperature.  Hydrolysis was  terminated  by 
washing the SaC pellet once in high-salt-NP-40 wash buffer. 
Hybridoma Antibodies.  Monoclonal hybridoma anti-Igh-la antibodies were  generated and 
prepared as described previously (26, 34, 35). The seven antibodies used in this study are listed 
in Table I. 
Radioiodinated Igh- la Immunoglobulin Fragments.  Preparations of Fab and Fc fragments of Igh- 
la proteins by papain (Worthington Biochemical Corp., Freehold, N. J.) digestion, and (Fab')2 
and  (Fabc)2 fragments by limited proteolysis with S.  aureus protease V8  (Miles Laboratories, 
Inc., Miles Research Products) was as described previously (34).  Fig. 5 is a schematic diagram 
of the heavy chain domain composition of these fragments. These fragments were labeled with 
Na[a25I] using 1,3,4,6-tetrachloro-3a,6a-diphenylglyoluril  (Iodogen, Pierce Chemical Co., Rock- 
ford, Ill.) as described (34,  36).  Immunoprecipitation of labeled fragments with  hybridoma 
antibodies was carried out using a solid-phase plate-binding procedure. Hybridoma antibodies 
(30 #1) were coated onto the well bottoms of flexible plastic 96-well plates (Cooke Laboratory 
Products, Division of Dynatech Laboratories, Alexandria, Va.)  at 50 #g/ml  in 50  mM Tris- 
HCI, 0.15  M  NaCI, pH 8.1,  that contained 50 #g/ml bovine serum albumin (BSA) for 1 h at 
room temperature. Excess reagent was removed and the free protein-binding sites in the wells 
were saturated by washing the plate with  1% BSA in PBS. Radioiodinated fragments in 30 #1 
were then added to the solid-phase antibodies for  1 h at room temperature. Excess label was 
removed by washing again with 1% BSA in PBS. Labeled fragments specifically bound to the 
plates were eluted with SDS-sample buffer for gel analysis (23). 
Results 
Membrane  2PK3  Immunoglobulin  Is  Larger  and  More  Acidic  Than  Its  Secreted 
Homologue.  The  immunoglobulin  heavy  chain  precipitated  from  surface-iodinated 
2PK3 cells with SaC or with SaC coated with hybridoma antibody Ig(la) 14.4 is larger 
and  more  acidic  than  the  biosynthetically labeled  heavy  chain  secreted  into  the v. Ol,  v. BRYAN, L.  HERZENBERG, AND L.  HERZENBERG  1263 
culture supernate of 2PK3 cells (Fig.  1). Fig.  1 A shows the heavy and light chains of 
secreted IgG precipitated from culture supernate of 2PK3 cells grown under biosyn- 
thetic labeling conditions. The line of related spots obtained from this monoclonally 
derived  immunoglobulin  heavy chain probably result  from the deamination  of the 
polypeptide chain.  Similar modification of the 2PK3 light chain is less apparent. 
Fig.  1 B  shows  the  membrane heavy and  light  chains  precipitated  from surface- 
iodinated  2PK3 cells. The major heavy chain spots have a  higher Mr and are more 
acidic than the secreted heavy chain.  A  trace of material is seen where the secreted 
IgG is found in Fig.  1 A. This may represent IgGjust being secreted or precursor IgG 
from dead cells present  in  the cell preparation used for radioiodination.  The mem- 
brane heavy chain has an Mr of ~65,000,  whereas the secreted chain has an Mr of 
-55,000.  Both Fig.  1 A and B show identical light chain spots. 
Fig.  1 C  shows that  both immunoglobulin molecules described  above are precipi- 
tated  from  extracts  of biosynthetically  labeled  2PK3  cells.  The  higher  molecular 
weight  chain  is  in  the  identical  position  as  the  surface-iodinated  membrane heavy 
chain. The lower molecular weight heavy chain, which migrated to the same position 
as  the  secreted  IgG  found  in  culture  supernate,  probably  represents  the  cellular 
precursor to secreted IgG. 
The Apparent  Molecular  Weight Difference between Membrane and Secreted IgG Is Not a 
Result  of Different N-Glycosidic-linked  Oligosaccharide Chains.  Studies with tunicamycin 
and  endoglycosidase  H  show  that  the  difference between  membrane  and  secreted 
2PK3 IgG is not a result of different asparagine-linked glycosylation of a single heavy 
chain precursor. Tunicamycin selectively inhibits asparagine-linked IgG heavy chain 
glycosylation  (30).  Fig.  2  shows  that  after tunicamycin  treatment,  both  membrane 
and secretory heavy chain  from labeled 2PK3 extracts have lower Mr  (panel B).  In 
Fig.  2 and subsequent  figures, only the heavy chain  regions of the two-dimensional 
gels are shown.  Blocking the addition  of asparagine-linked oligosaccharide chains to 
2PK3 immunoglobulin heavy chains does not affect the presence of the two biosyn- 
thetic  molecules  in  2PK3  cell  extracts.  Therefore,  the  Mr  and  net  electrophoretic 
charge difference between membrane and secretory IgG is not a result of different N- 
glycosidic-linked oligosaccharides. 
The reduction in Mr of both membrane and secreted molecules after tunicamycin 
treatment  is  about  1,000-2,000.  It  is  interesting  to  note  here  that  the  preformed 
oligosaccharide core transferred from the dolichol pyrophosphate intermediate has an 
Mr of -2,000 (28). It also should be noted, in agreement with other studies (30), that 
the nonglycosylated, intracellular secretory IgG made in the presence of tunicamycin 
is secreted as such into the culture supernate (Fig. 2 D). 
Two IgGza heavy chains, corresponding to the membrane and secreted molecules, 
also  are  seen  after  endoglycosidase  H  was  used  to  remove  the  high  mannose  N- 
glycosidic-linked  oligosaccharide  core  from  internal  IgG2a heavy chain  precursors. 
The  oligosaccharide  chain  of only  some  of  the  cellular  2PK3  heavy  chains  are 
susceptible  to  hydrolysis  (Fig.  3).  Both  secretory and  membrane forms are equally 
affected, indicating that some of both IgG2a heavy chains have unprocessed oligosac- 
charide  chains.  This  is  seen  as  the  new  lower  molecular  weight  spots  in  Fig.  3B 
(compare with Fig. 3 A), which also are comparable to the nonglycosylated molecules 
seen  after  tunicamycin  treatment  (Fig.  2).  As  expected,  no  effect  was  seen  with 
endoglycosidase H  treatment of already secreted 2PK3 IgG (Fig. 3 C  and D). Flo.  1.  Autoradiographs of two-dimensional polyacrylamide gels of secreted and membrane 2PK3 
immunoglobulins. (A) Secreted IgG2a precipitated from culture supernate of 14C-labeled  2PK3 cells 
with SaC coated with hybridoma antibody Ig(la)14.4.  (B) Membrane IgG2a precipitated from 12sI- 
surface-labeled 2PK3 cell extract with SaC coated with the same hybridoma antibody. (C) Cellular 
IgG2a precipitated from  14C-labeled  2PK3  cell extract  with Ig(la)14.4-coated  SaC.  All autoradi- 
ographic exposures were for 1 d. 
1264 FIG.  2.  Effects of tunicamycin on membrane and secreted IgG~, heavy chains. (A) SaC precipitate 
of cell extract  from  [~S]methionine-labeled 2PK3  cells.  (B)  SaC  precipitate of cell extract  from 
2PK3  cells labeled with  [35S]methionine in  the presence of tunicamycin.  (C)  SaC  precipitate of 
culture supernate from [35S]methionine-labeled 2PK3 cells. (D) SaC precipitate of culture supernate 
from 2PK3 cells labeled with [~S]methionine in the presence of tunicamycin. In (B), arrows point 
to  the  nonglycosylated membrane  and  secretory heavy chains.  In  (D),  the  arrow  points to  the 
nonglycosylated secreted IgG2a heavy chain. Molecular weight standards (Pharmacia Fine Chemi- 
cals, Div. of Pharmacia, Inc., Piscataway, N. J.), indicated on the right side of each autoradiograph, 
were included in each gel and visualized by protein staining. The 67,000 mol wt (BSA) marker has 
a  similar  charge  to  the  membrane  IgGza  heavy chain,  providing  an  excellent  two-dimensional 
marker for visualizing the decrease in Mr of the nonglycosylated IgG2~ heavy chain. All autoradi- 
ographic exposures were for 1 d. In this and subsequent figures, only the heavy-chain region of the 
two-dimensional gel are shown. 
FIG.  3.  Effects of hydrolysis with  endoglycosidase H  on  membrane  and  secreted  IgG2a  heavy 
chains.  (A)  SaC  precipitate of secretory and  membrane heavy chains from  cell extracts of [35S]- 
methionine-labeled 2PK3 cells. (B)  Endoff,  lycosidase-H-treated SaC  precipitate of membrane and 
secretory heavy chains from extracts of [_  S]methionine-labeled 2PK3 cells. (C)  SaC precipitate of 
secreted heavy chains from culture supernate of [~S]methionine-labeled 2PK3 cells. (D)  Endogly- 
cosidase-H-treated SaC precipitate of secreted heavy chains from culture supernate of [35S]methio- 
nine-labeled 2PK3 cells. All autoradiographic exposures were for 1 d. 
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FIG. 4.  Immunoprecipitation  of 12~I-surface-labeled  2PK3 IgG2a heavy chains.  (A)  Precipitation 
with  Ig(la)14.4-coated  SaC  (l-d  autoradiographic  exposure  with  an  intensifying  screen). (B) 
Precipitation  with  Ig(la)15.3-coated  SaC  (3-d autoradiographic  exposure  with  an  intensifying 
screen). (C) Precipitation  with uncoated  SaC (l-d autoradiographic  exposure with an intensifying 
screen). 
Membrane IgG2a Lacks an Allotypic Determinant Present on Secreted IgG2a.  Six different 
hybridoma  anti-Igh-la  antibodies  precipitated  secreted  2PK3  IgG2a,  however,  only 
five of these  antibodies  precipitated  the  membrane  molecule.  The sixth,  Ig(la) 15.3, 
reacted  poorly,  if at  all  with  the  membrane  molecule  although  its  precipitation  of 
secreted molecule was about equal to the other antibodies.  Fig. 4 shows the gel pattern 
of the  surface-iodinated  2PK3  cell  extracts  precipitated  with  Ig(la)14.4  (Fig.  4A), 
which  is typical of the  five antibodies  that  are reactive with both  IgG molecules and 
with  Ig(la)15.3  (Fig.  4B).  The  contaminating  secretory-type  IgG  in  the  surface- 
iodinated  extract  clearly  is  evident  in  both  precipitates.  The  Ig(la)15.3  precipitate 
presented  here shows a  trace of membrane  molecule;  however,  in other experiments, 
the  membrane  heavy  chain  is  totally  absent.  It  is  important  to  note  here  that  the 
autoradiograph  of the  Ig(la)15.3  precipitate  shown  in  Fig.  4B  is  a  3-d  exposure, 
whereas  Fig.  4A  is an  autoradiograph  exposed  for  1 d.  This  experimental  variation V.  OI, V.  BRYAN,  L.  HERZENBERG,  AND  L.  HERZENBERG 
S-Aureus protease 
fragments 
Fd' l  Fdc  l 
2~K  46K 
c> Iglla)15.3 
Q Ig(1a)14.4 
Papain fragments 
Fc 
'COOH 
Fro. 5.  Schematic diagram of enzymatic cleavage sites and location of allotypic determinants on 
secreted IgG2a (Igh-la). Fd and Fc are the heavy chain components of the papain-derived Fab and 
Fc dimer fragments. Fd consists of the VH and CHI domains, and Fc consists of most of the CH2 and 
all of the CH3 domains. The hinge region and probably some of the CH2 domain  are lost with 
papain digestion. Fd' and Fdc are the heavy-chain components of the S. aureus-protease-V8-derived 
(Fab')2 and (Fabc)2 fragments. Fd' consists of the VH, CH1, hinge, and some of the CH2 domains. 
Fdc consists of Vn, Cn 1, hinge, CH2, and probably some of the CH3 domains. The S. aureus protease 
fragments described here are larger than was reported previously (34). This appears to be a result 
of the batch of enzyme used. The location of the allotypic determinants on GPC-8 myeloma protein 
recognized by hybridoma antibodies Ia(la)15.3 and Ig(la)14.4, based on results presented in Fig. 6, 
are shown. These results must be interpreted in view of results obtained with another Igh- la protein 
presented in the text. 
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may reflect how efficiently the SaC is coated with hybridoma antibody; free protein- 
A  sites on  the  SaC would bind  the membrane  form.  Fig. 4C  shows  the precipitate 
using uncoated SaC. 
The  Location  of  the  Missing  Membrane  Allotypic  Determinant  on  Secreted  IgGaa 
Molecules.  The location of the determinant recognized by each hybridoma antibody 
was  determined  by  testing  the  reactivity of these  antibodies with  GPC-8  (Igh-la) 
myeloma  protein  fragments  (Fig.  5).  Both  Ig(la)16.3  and  Ig(la)14.4  antibodies 
precipitate the Fc, the  (Fab')2, and  (Fabc)2 fragments derived from  GPC-8  (Fig. 6). 
On the other hand, although Ig(la) 15.3 precipitates the (Fab')z and (Fabc)z fragments, 
it reacts poorly, if at all with the GPC-8 Fc fragment (Fig. 6). None of the hybridoma 
antibodies reacts with Fab fragments. 
From  these results it would appear that  the allotypic determinant  recognized by 
Ig(la)15.3  is  located  in  or  near  the  hinge  region  of GPC-8.  After  this  paper  was 
submitted,  however,  we  found  that  Ig(la)15.3  reacts  with  the  Fc  fragment  from 
another Igh-la protein, a  hybridoma-derived protein called 29-B. 1 (34). Both GPC-8 
and  29-B.1  Fc  fragments  were  made  with  the  same  digestion  procedure  and  both 
have the same Mr when analyzed by SDS-polyacrylamide gel electrophoresis, yet the 
allotypic determinant on GPC-8 recognized by Ig(la) 15.3 is lost after papain digestion, 
whereas the 29-B. 1 Fc retains reactivity. In view of these results, a  general conclusion 
on the location of this determinant on secreted Igh-la proteins cannot be made. 
The determinant on GPC-8 is not at the carboxy-terminus of the molecule, because 
the (Fab')2 and (Fabc)2 fragments from GPC-8 react with Ig(la) 15.3. The intact GPC- 
8 hinge region either contains the determinant or somehow affects reactivity with the 
determinant,  located elsewhere on  the molecule. This could be a  result  of a  genetic 
difference  between  the  two  proteins.  GPC-8  was  derived  from  a  BALB/c  subline 
maintained in Australia which has been separated from  the BALB/cN subline since 1268  LYMPHOCYTE  MEMBRANE  IgG 
FIG. 6.  Immunoprecipitation of Igh-la immunoglobulin  fi'agments with  hybridoma antibodies. 
(A) shows the fragments precipitated from a mixture of 125I-labeled  Fab and Fc fragments (derived 
by limited proteolysis [with papain] of GPC-8, an Igh- la myeloma protein) with Ig(la) 16.3 (lane 1), 
Ig(la) 15.3 (lane 2), Ig(la)14.4  (lane 3), and Ig(4a)10.9 (lane 4). This is a  10% SDS-polyacrylamide 
slab get run under nonreducing conditions. (B) shows the fragments precipitated from a mixture of 
(Fab')2 and (Fabc)2 fragments (derived by limited proteolysis [with S. aureus protease V8] of GPC-8 
myeloma  protein)  with  the same  hybridoma antibodies  described  in  (A). This  is a  10%  SDS- 
polyacrylamide  slab  gel run  under  reducing  conditions.  The  heavy  chain  components  of each 
fragment  (see Fig. 5)  and the light  chain  are indicated on  the left side of the autoradiograph. 
Autoradiographic  exposures were for 3 d with intensifying screens. 
1952  (Dr.  Noel  L.  Warner.  Personal  communication.).  29-B.1  was  derived recently 
from the BALB/cN subline. 
Removal of the  N-Glcosidic-linked Oligosaccharide on  Secreted IgG2a Does Not  Affect  the 
Expression of the Ig(la)15.3 Allotypic Determinant.  We have already demonstrated that 
different N-glycosidic-linked oligosaccharide chains do not account  for the difference 
in Mr and electrophoretic charge between membrane and secreted IgG2a. Our results 
also demonstrate that  the nonglycosylated secretory heavy chain precursor in  2PK3 
cells treated with tunicamycin is precipitated with Ig(la)15.3  (gel not  shown).  Thus 
the  removal  of  the  oligosaccharide  chain  on  secreted  IgG2,  does  not  affect  the 
expression of the Ig(la)15.3 allotypic determinant. 
Nonglycosylated Membrane IgG2,~ Heavy Chains Do Not Appear to Express Allotypic Deter- 
minants.  We  are  not  certain  whether  the  nonglycosylated membrane  molecule ex- 
presses the Ig(la)15.3 determinant.  It is conceivable that the membrane N-glycosidic- 
linked oligosaccharide masks  this  allotypic determinant.  We have  not  been  able to 
test this possibility because it appears that nonglycosylated membrane molecules are 
not precipitated with any of the hybridoma antibodies. 
In untreated 2PK3 cell extracts, only a  portion of the immunoglobulin precipitable 
with  SaC  is  precipitable with  hybridoma  antibodies.  Cell  extracts  that  have  been 
exhaustively cleared of immunoglobulin reactive with hybridoma antibodies still have 
immunoglobulin  that  is  precipitable  with  SaC,  This  is  true  for  membrane  and 
secretory  molecules  that  are  precipitable with  Ig(la)14.4,  which  reacts  with  both 
molecules, and for secretory molecules precipitable with Ig(la)15.3 (data not shown). 
A  possible explanation for this may be that  the expression of some allotypic and/or 
isotypic determinants are dependent on intracellular IgG tetramer assembly; protein 
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In  tunicamycin-treated  cell  extracts,  the  reactivity of nonglycosylated secretory 
heavy chains with hybridoma antibodies is indistinguishable from their glycosylated 
homologues; however, the amount of nonglycosylated membrane heavy chain that is 
precipitable  with  Ig(la)14.4,  which  precipitates  some  of the  internal  glycosylated 
membrane heavy chain, is small, if present at all, compared with SaC precipitation. 
(Fig. 2 B shows the SaC precipitate of tunicamycin-treated cell extracts.) It appears 
that the expression of some allotypic determinants on membrane IgG2~ heavy chains 
and not secretory heavy chains is dependent on asparagine-linked glycosylation. We 
do  not  know  the  molecular  basis  of this  result.  It  may  be  that  glycosylation  is 
important  for the proper folding of the membrane heavy chain or the assembly of 
membrane IgG tetramer, and these processes are required for determinant expression. 
One might expect that two distinct assembly pathways for membrane and secretory 
molecules are needed in a single cell that produces both molecules. These pathways 
would be dependent on structural differences (perhaps in the hinge region) between 
the membrane and secreted molecules. This would explain why mixed IgG2~ tetramers 
that  consist  of two  light  chains  associated  with  one  membrane  and  one secretory 
heavy chain  have not  been seen  (Fig.  2A and  B).  Precedents for protein structure 
affecting assembly patterns have been described (37, 38). 
Discussion 
We have demonstrated that membrane and secreted IgGza from a monoclonal cell 
line are  different on the basis  of Mr,  net  charge,  and  allotypic determinants.  The 
charge and  molecular-weight differences are  not  a  result  of different N-glycosidic- 
linked oligosaccharides, but the possibility that the membrane molecule has additional 
serine- and/or threonine-linked glycosylation sites has not been excluded rigorously. 
Such  O-glycosidic-linked oligosaccharides could account for the differences between 
the membrane and  secreted heavy chains described here;  however, the presence of 
additional  sites  for oligosaccharide attachment  would  suggest  that  membrane and 
secreted heavy chain molecules have primary-amino-acid-sequence differences. 
The allotypic determinant recognized by Ig(la)15.3 was shown not to be affected 
by removal of the N-glycosidic-linked oligosaccharide chain on secreted IgGza mole- 
cules. Because secreted IgG molecules are known to have a single asparagine-linked 
oligosaccharide chain, we are certain that the Ig(la)15.3 allotypic determinant is not 
this carbohydrate structure. It still is conceivable however, that the asparagine-linked 
oligosaccharide on membrane heavy chains is sufficiently different that it masks this 
allotypic  determinant.  There  are  previous  indications  that  membrane-associated 
immunoglobulins appear to lack allotypic and isotypic antigenic determinants found 
on secreted molecules (39-41). Some of these studies show that determinants near the 
carboxy terminus  of the  immunoglobulin  apparently  are  inaccessible  to  antibody 
probes. The absence of the Ig(la)15.3 determinant on detergent-solubilized molecules 
makes this an unlikely explanation for our results. 
A  recent study  (42)  indicated  that  IgG  isolated  from mouse spleen cell extracts 
behaves as though it contains a hydrophobic region. Our own preliminary data from 
charge-shift electrophoresis (43) experiments confirm this result. This would indicate 
that  the membrane IgG2~ heavy chain we have described is an  integral membrane 
protein. 
Membrane IgM and IgD clearly contain hydrophobic structures that could anchor 1270  LYMPHOCYTE MEMBRANE IgG 
them in membranes (43,  44); 2 however, there are no published  primary amino acid 
sequence  data  demonstrating  this  extra  hydrophobic  segment.  Although  peptide- 
mapping  studies  demonstrate  that  there  are  differences  between  membrane  and 
secreted IgM heavy chains (10), the location of these peptide differences has yet to be 
determined. 
Our  data,  demonstrating  a  missing  allotypic  determinant  on  membrane  IgG, 
suggest  that  a  primary structural  difference occurs  in  the  Fc part  of the  molecule. 
Taken  together  with  the  evidence  that  membrane  IgG may  have  a  hydrophobic 
sequence anchoring it in the membrane, it would appear that there may be significant 
structural differences between membrane and secreted IgG2a heavy chains, one within 
the Fc part of the molecule and the other near the carboxy-terminus (for which there 
is no direct evidence). This structural model would account for the molecular weight, 
charge,  and  allotypic  differences  between  the  two  molecules.  It  also  provides  a 
structural  basis for the faithful assembly of membrane and secreted  tetrameric IgG 
molecules in the same cell. 
Two other structures also could explain the differences described here. One is that 
the addition of a carboxy-terminal hydrophobic segment to membrane IgG2a induces 
a  conformational change  in  another  region  of the  heavy chain,  accounting  for the 
absence of the Ig(la) 15.3 allotypic determinant. The other is that a primary structural 
difference in the membrane molecule induces a conformational change in the carboxy- 
terminus,  exposing a  hydrophobic  region  which  then  anchors  the  molecule  in  the 
membrane. It is conceivable that different membrane heavy chain homologues could 
adopt any of these structural strategies. 
Structurally distinct  membrane and secretory molecules of the same immunoglob- 
ulin heavy chain class could be generated in two ways: (a) there could be two distinct 
cistrons  coding  for  membrane  and  secreted  molecules;  or  (b)  an  alternate  RNA 
splicing mechanism could yield similar but different messenger RNA (mRNA)  from 
the same primary RNA transcript, which are translated into membrane and secreted 
heavy chains. From peptide mapping studies (10), it appears that the primary amino 
acid sequences of membrane and secreted IgM heavy chains are very similar (though 
not  identical).  Allotypic  and  isotypic  determinants  also  are  generally  conserved 
between  membrane  and  secreted  molecules.  If there  are  distinct  cistrons  for each 
molecule, w.e would expect more divergence in allotypy and isotypy between  mem- 
brane and secreted products. 
We feel that it is more likely that an alternate mRNA splicing mechanism generates 
both  gene  products  from  the  same  DNA  sequence.  Recently,  the  entire  genomic 
sequence of the (secreted) IgG2b (Igh-3a) heavy chain cistron was completed (45,  46). 
There is a  300 base intron separating the CH1  and hinge exons that is large enough 
to accomodate an  additional  hinge  region  exon.  An  alternate  hinge exon could  be 
either  entirely  in  the  intron  or  overlap  the  secreted  hinge  exon.  An  overlapping 
sequence could be read in or out of frame, resulting in shared or different Fc sequences. 
Simian  virus  40  (SV40)  genomic  expression  provides  an  excellent  precedent  for 
such an RNA splicing mechanism (47).  Two early mRNA, arising in SV40-transfor- 
mation  code  for  two  serologically  and  biochemically  similar  transformation  (T) 
antigens. These have been shown to be derived from overlapping viral genomic DNA 
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sequences (48, 49). Alternate RNA splicing may be a general mechanism for synthe- 
sizing two (or more) different, but nearly identical, proteins. Recently, a third SV40 
early mRNA  has been described that  also shares T  antigen-coding sequences  (50). 
This mRNA represents an additional  RNA splicing product that  may code for the 
tumor-specific transplantation antigen (TSTA) found associated with membranes of 
SV40-transformed  cells  (50,  51).  TSTA  is  serologically  indistinguishable  from  T 
antigen (51).  Examination of the SV40 genomic sequence that codes for this mRNA 
transcript has suggested that translation read out-of-phase at the 3' end of the viral 
cistron (relative to the T-antigen-coding sequence) would yield a polypeptide with a 
hydrophobic carboxy-terminus (50). A  similar mechanism could operate on immu- 
noglobulin cistrons, yielding a membrane anchor for IgG heavy chains. 
The  difference  between  membrane  and  secreted  IgG2a  also  could  play  a  key 
functional role in T  cell regulation of antibody formation. B cell differentiation and 
antibody production is known to be regulated by both carrier-specific and Ig-specific 
helper T  cells (52-57). The molecular basis for the interaction between Ig-specific T 
cells and Ig-bearing B cells has been a puzzle. It has always been difficult to imagine 
such a recognition process occuring in the presence of secreted molecules sharing the 
same antigenic determinants.  Some of the recognition sites must also be genetically 
polymorphic, because allotype-specific recognition by T  cells has been observed in 
allotype-heterozygous mice (56, 57). Polymorphic determinants unique to membrane 
immunoglobulin then might be the recognition sites by which such interactions occur. 
Summary 
We have demonstrated that there are structurally distinct membrane and secreted 
IgG~  immunoglobulin  molecules.  The  membrane  heavy chain  is  both  larger  and 
more acidic than the secreted molecule. This difference is not a result of different N- 
glycosidic-linked oligosaccharide chains. The membrane heavy chain also is antigen- 
ically different from its secreted homologue. This is based on the fact that  secreted 
IgG2a molecules express an allotypic determinant absent on membrane molecules. 
We discussed the genetic control and gene organization of membrane and secreted 
immunoglobulin  heavy  chain  sequences  and  suggest  mechanisms  controlling  the 
expression of the simian virus 40 genome as models for alternate gene expression of 
membrane and secreted heavy chain polypeptide chains from the same DNA sequence. 
The possible biological significance of the  membrane immunoglobulin  acting as  a 
recognition  site  for  regulatory  T  cells  also  is  discussed.  The  difference  between 
membrane and secreted immunoglobulin is proposed as a possible explanation for the 
manner in which T  cells interact with IgG on memory B cells in the presence of a 
large excess of IgG present in body fluids. 
Received  for publication 31 January 1980. 
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